The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis
Source : https://nn.neurology.org/content/8/5/e1043.abstract
Objective To evaluate the aryl hydrocarbon receptor (AHR)-dependent transforming growth factor alpha (TGF-α)/vascular endothelial growth factor B (VEGF-B) ratio, which regulates the effects of metabolic, dietary, and microbial factors on...
Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations
Source : https://www.mdpi.com/2076-393X/9/7/773
Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine response dynamics. A systematic review on...
Preferences for Multiple Sclerosis Treatments in the US | PPA
Multiple sclerosis (MS), a chronic inflammatory disease, involves damage to the central nervous system and impairments in neurologic function. More than 2 million people worldwide have MS, with nearly 1...
